GF
Therapeutic Areas
AviadoBio Pipeline
| Drug | Indication | Phase |
|---|---|---|
| AVB-101 | Frontotemporal Dementia with GRN mutations (FTD-GRN) | Phase 1/2 |
| Program(s) for Retinitis Pigmentosa | Retinal Dystrophies | Pre-clinical |
| Program(s) for ALS | Amyotrophic Lateral Sclerosis | Pre-clinical |
| Program(s) for Tauopathies | Alzheimer's Disease and other Tauopathies | Pre-clinical |